Malignant mesenterial mesothelioma in stroke patients

Dewa Gde Agung Budiyasa1, I Dewa Nyoman Wibawa

  • 1Department of Internal Medicine Udayana University-Sanglah General Hospital. Jalan Kesehatan 1, 80229 Denpasar, Bali. srimartini@hotmail.com

Acta Medica Indonesiana
|January 20, 2009
PubMed

Insights

This case report details a rare instance of malignant mesenteric mesothelioma in a 64-year-old man, presenting with ascites and neurological deficits. The aggressive tumor led to a high fatality rate despite optimal treatment efforts.

Area of Science:

  • Oncology
  • Gastroenterology
  • Neurology

Background:

  • Malignant mesothelioma is an aggressive tumor originating from mesothelial cells, with malignant mesenteric mesothelioma being a rare subtype.
  • The case involves a 64-year-old Balinese man with a history of liver disease, presenting with complex symptoms.

Observation:

  • The patient exhibited weakness, abdominal enlargement, nausea, decreased consciousness, ascites, and left-sided paralysis.
  • Laboratory findings included leukocytosis, anemia, thrombocytosis, hypoalbuminemia, elevated alkaline phosphatase, and mild hyponatremia.
  • Imaging revealed an intraperitoneal mass, ascites, and cerebral infarction; endoscopy showed esophagitis and gastritis.

Findings:

  • Cytology and Fine Needle Aspiration Biopsy (FNAB) confirmed malignant mesothelioma.
  • The final diagnoses included malignant mesenteric mesothelioma, reflux esophagitis, anthral erosive gastritis, and non-hemorrhagic stroke.

Implications:

  • Malignant mesenteric mesothelioma should be considered in patients with unexplained ascites and abdominal pain.
  • Optimal treatment is crucial for improving the quality of life, even in cases with a poor prognosis.